West Pharmaceutical Services, Inc. and HealthPrize Technologies, LLC have entered a strategic collaboration to integrate HealthPrize’s Software-as-a-Service (SaaS) medication adherence platform with West’s injectable drug delivery systems. The combined offering will provide electronically-connected drug delivery systems that track when patients take their medication, educate and engage patients to increase adherence and medical literacy, and reward them for compliance.
  
HealthPrize programs have demonstrated high engagement rates and materially higher adherence rates, nearly 50% higher than baseline, according to the company. In collaboration with West’s self-injected drug delivery systems, such as SmartDose, SelfDose, and ConfiDose, HealthPrize will also offer real-time verification of medication usage via wireless connection to West’s drug delivery systems, including various biologics and other self-injected therapies.
  
The companies are also implementing additional data transfer technologies into the platform including smart labels, RFID/NFC and QR-code scanning. West plans to develop a system technology that will allow both West drug delivery systems as well as existing drug delivery devices of other manufacturers to interface with the HealthPrize software.
 
“We believe the unique and exclusive combination of the West drug delivery platforms with leading patient adherence software from HealthPrize provides a powerful partnership to be by our customers’ side to help improve patient compliance and health outcomes,” said Donald E. Morel, Jr., chairman and chief executive officer, West.